Molecular Diagnostics, the IVD industry’ segment, refers to the tests measuring DNA and RNA, as well as various products of metabolism to discover mutations, specific genotypes or any biochemical alterations which may be linked to certain health states or disease conditions. This science owns its emergence to the advancements in biology that have deepened the knowledge of the mechanisms of molecular-level processes, both normal and malignant.
Molecular Diagnostics is by far the most hastily progressing sector. The oncoming decade will be ear-marked by far-reaching advances in reagent and automation systems, along with the advent of a generous assortment of novelties set to inevitably call for innovative marketing techniques. The percentage of market penetration into day-to-day habitual clinical lab settings, though, will revolve around the arrival of money’s worth and automatized systems with amplification techniques. Some of the firms reigning over the market are Abbott Diagnostics, Celera, Sysmex Corporation, Roche Diagnostics, Qiagen N.V., Siemens Medical Solutions Diagnostics, and more.
The research reports from this Catalogue look at the Molecular Diagnostics Market on every imaginable geography level, covering key technology and medical trends. The issues mentioned in the research reports are varied, ranging from market sizing, share and segmentation to new product introductions and regulatory landscape. Further, the research reports highlight market penetration strategies, potential enter barriers, competitive profiles, besides offering the Molecular Diagnostics Market forecasts.
Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2020
... Access to over 640 monoclonal antibodies deal records The leading monoclonal antibodies deals by value since 2014 Includes chimeric mAb, humanized mAb, human mAb and murine mAb deals and alliances since 2014 In Global Monoclonal antibody Partnering Terms and Agreements 2014 to 2098 ...
In-Vitro Diagnostics Market by Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) - Global Forecast to 2025
... Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers & Microbiology Culture) – Global Trends & Forecasts to 2016 The global in-vitro diagnostics (IVD) market was valued at $44 billion in 2011 and is expected to have a modest growth during the study period. The U.S. represented the biggest market for IVD ...
Global PCR & Real-time PCR Molecular Diagnostics Market Size study, by Technology (Traditional PCR, Real-time PCR, Digital PCR), By Product (Instruments, Reagents and Consumables), By Application (Infectious Diseases Testing and Oncology Testing), By End-Users (Hospitals, Diagnostic Laboratories, Academic & Research Centers and Others) and Regional Forecasts 2020-2027
Global PCR & Real-time PCR Molecular Diagnostics Market is valued approximately USD 4.10 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 4.00% over the forecast peri...
India Molecular Diagnostics Market By Application (Infectious Disease, Blood Screening, Genetic Testing, Oncology Testing), By Technology (PCR, In-situ Hybridization, Chips and Microarrays, Mass Spectrometry, Sequencing, Others), By End User (Hospitals, Academic & Reference Laboratories), By Region, Competition, Forecast & Opportunities, FY 2026
India molecular diagnostics market stood at an estimated $ 920 million in FY 2020 and is projected to grow at a CAGR of around 10% until FY 2026, predominantly on account of rising cases of fatal and...
Global Molecular Diagnostics Market, 2020-2026
The global molecular diagnostics market size was valued at $12,134.69 million in 2019 and is projected to reach $21,716.83 million by 2026, registering a CAGR of 8.67% from 2020 to 2026. The molecular...
2020 World Molecular Diagnostic Analyzer and Reagent Forecasts for 100 Tests: Americas, EMEA, APAC-A 68-Country Analysis-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing-Supplier Shares, Emerging Technologies, Instrumentation Review, Opportunities
... Current and Emerging Products Analysis of current and emerging molecular blood typing, grouping and infectious disease NAT screening assays. Review ... test. Strategic Recommendations New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation ...
Point of Care Molecular Diagnostics Market by Product and Solution (Assay, Analyzer, Software, Services), Technology (RT-qPCR, INAAT), Application (Respiratory Diseases, Hospital Acquired Infections, STD), and End User - Global Forecast to 2027
Point of Care Molecular Diagnostics Market by Product & Solution (Assay, Analyzer, Software, Services), Technology (RT-qPCR, INAAT), Application (Respiratory Diseases, Hospital Acquired Infections, ST...
Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Test Location, By Technology, By Application, By Region, And Segment Forecasts, 2020 - 2027
The global molecular diagnostics market size is expected to reach USD 19.8 billion by 2026, according to a new report by Grand ... segment Based on test location, central laboratories led the market with the largest market share in 2018 owing to their established base in the remote ...
Molecular Diagnostics Global Market - Forecast to 2026
There is an emerging trend towards precision health in today’s world to enhance disease diagnosis, treatment, prevention and monitoring by using innovative diagnostic technologies with broader range a...